A new research project aims to determine whether medications developed to treat depression might be viable candidates for easing some troubling side effects of treatments for Parkinson’s disease, including levodopa. Parkinson’s is caused by the death or dysfunction of cells in the brain that make a neurotransmitter (brain signaling molecule) called dopamine. A standard treatment involves the administration of L-dopa, a molecule that can be converted to dopamine in the brain. L-dopa therapies for Parkinson’s include…

You must be logged in to read/download the full post.